Multisubstrate Adduct Inhibitor Uses, Dosage, Side Effects and more
| Attribute | Details |
|---|---|
| Trade Name | Multisubstrate Adduct Inhibitor |
| Generic | N-[4-([(2-Amino-4-oxo-1,4-dihydropyrido[3,2-d]pyrimidin-6-yl)methyl]{(2E)-3-[4-carbamoyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazol-5-yl]-2-propenoyl}amino)benzoyl]-L-glutamic acid |
| N-[4-([(2-Amino-4-oxo-1,4-dihydropyrido[3,2-d]pyrimidin-6-yl)methyl]{(2E)-3-[4-carbamoyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazol-5-yl]-2-propenoyl}amino)benzoyl]-L-glutamic acid Other Names | beta-DADF, MSA, multisubstrate adduct inhibitor, β-DADF, MSA, multisubstrate adduct inhibitor |
| Type | |
| Formula | C32H34N9O15P |
| Weight | Average: 815.6374 Monoisotopic: 815.191197975 |
| Groups | Experimental |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
